aTyr Pharma (LIFE) Earnings Date, Estimates & Call Transcripts → Urgent Nvidia Warning (From Altimetry) (Ad) Free LIFE Stock Alerts $1.61 +0.01 (+0.63%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 2) -$0.23 Beat By $0.01 Consensus EPS (May. 2) -$0.24 Read Call Transcript Get aTyr Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for LIFE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLIFE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LIFE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. aTyr Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.97) EPSNext Year EPS Consensus Estimate: ($1.03) EPSLIFE Earnings Date and InformationaTyr Pharma last released its earnings data on May 2nd, 2024. The biotechnology company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.01. The company earned $0.24 million during the quarter, compared to analyst estimates of $0.11 million. aTyr Pharma has generated ($0.90) earnings per share over the last year (($0.90) diluted earnings per share). Earnings for aTyr Pharma are expected to decrease in the coming year, from ($0.97) to ($1.03) per share. aTyr Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More aTyr Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024Estimated)------- 5/2/2024Q1 2024($0.24)($0.23)+$0.01($0.23)$0.11 million$0.24 million 3/14/2024Q4 2023($0.23)($0.25)($0.02)($0.25)--11/9/2023Q3 2023($0.21)($0.20)+$0.01($0.20)$6.00 million$0.35 million8/9/2023Q2 2023($0.27)($0.22)+$0.05($0.22)--5/9/2023Q1 2023($0.39)($0.29)+$0.10($0.29)--3/9/2023Q4 2022($0.48)($0.26)+$0.22($0.26)$1.50 million$10.39 million Get the Latest News and Ratings for LIFE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for aTyr Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.45)($0.46)($0.01)($0.46)--8/15/2022Q2 2022($0.43)($0.44)($0.01)($0.44)-- 5/9/2022Q1 2022($0.34)($0.44)($0.10)($0.44)-- 3/14/2022Q4 2021($0.24)($0.31)($0.07)($0.31)-- 11/10/2021Q3 2021($0.53)($0.42)+$0.11($0.42)-- 8/9/2021Q2 2021($0.51)($0.64)($0.13)($0.64)-- 5/13/2021Q1 2021($0.34)($0.51)($0.17)($0.51)-- aTyr Pharma Earnings - Frequently Asked Questions When is aTyr Pharma's earnings date? aTyr Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on LIFE's earnings history. Did aTyr Pharma beat their earnings estimates last quarter? In the previous quarter, aTyr Pharma (NASDAQ:LIFE) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.24) by $0.01. Learn more on analysts' earnings estimate vs. LIFE's actual earnings. How can I read aTyr Pharma's conference call transcript? The conference call transcript for aTyr Pharma's latest earnings report can be read online. Read Transcript How much revenue does aTyr Pharma generate each year? aTyr Pharma (NASDAQ:LIFE) has a recorded annual revenue of $350,000.00. How much profit does aTyr Pharma generate each year? aTyr Pharma (NASDAQ:LIFE) has a recorded net income of -$50.39 million. LIFE has generated -$0.90 earnings per share over the last four quarters. What is aTyr Pharma's EPS forecast for next year? aTyr Pharma's earnings are expected to decrease from ($0.97) per share to ($1.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BioAtla Earnings Results Outlook Therapeutics Earnings Results bluebird bio Earnings Results Vigil Neuroscience Earnings Results Cardiol Therapeutics Earnings Results Sangamo Therapeutics Earnings Results Omega Therapeutics Earnings Results AlloVir Earnings Results Curis Earnings Results Vaxart Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:LIFE) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding aTyr Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
